Company intelligence / Profile preview

CardioMag Imaging

Schenectady, New York, USA

Ownership: Private
Development stage: Other

Overview

CardioMag Imaging (CMI) was a medical technology company that developed non-invasive magnetocardiography (MCG) systems for the diagnosis of heart disease. The company's core technology utilized highly sensitive Superconducting Quantum Interference Device (SQUID) sensors to measure the magnetic fields produced by the heart's electrical activity. This diagnostic approach was designed to detect coronary artery disease and myocardial ischemia more accurately and faster than traditional methods like EKG or stress tests. CMI's systems received FDA clearance and were marketed for use in emergency rooms to quickly triage patients with chest pain. In 2012, the company was acquired by the German medical device firm BMDSys.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on CardioMag Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CardioMag Imaging.

Explore the full profile